Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-06-20

FDA Approved: TYBOST — Supplemental Application (Gilead Sciences, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for TYBOST (cobicistat) submitted by Gilead Sciences.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tybost (Cobicistat)

Snippet

SUPPL AP for TYBOST (COBICISTAT)